TrialPloS one2016

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.

Baruch Brenner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.